文献速递创伤与烧伤心脑血管急症重症综合管理与镇静镇痛

大型动物模型:创伤性脑损伤合并两种不同程度失血的存活率与生物标志物

Survival Rates and Biomarkers in a Large Animal Model of Traumatic Brain Injury Combined With Two Different Levels of Blood Loss.
PubMed 文献 · Shock · 2021-01-01
一句话结论猪模型显示,旋转性创伤性脑损伤合并55%失血存活率仅12.5%,合并40%失血存活率87.5%;55%失血组多在伤后2小时内死于呼吸暂停。

该研究用22头性成熟Yucatan猪(30.39±2.25 kg,11头雌性)行假手术(n=6)或动态加速性创伤性脑损伤合并55%(n=8)或40%(n=8)失血。创伤性脑损伤合并40%失血组存活率87.5%,显著高于55%失血组的12.5%,55%失血组多数于伤后2小时内死于呼吸暂停。两组均出现弥漫性轴索损伤、血脑屏障破坏和炎症的血液及免疫组化证据,55%失血组代谢性酸中毒在伤后约85分钟仍持续加重。作者认为55%失血模型可能适合需要立即医疗干预/标准液体复苏的严重创伤研究,40%失血模型可能适合延长现场救治研究。

要点

  • 创伤性脑损伤合并55%失血组存活率12.5%,显著低于合并40%失血组的87.5%,55%失血组多数于伤后2小时内死于呼吸暂停。
  • 两组伤后均出现休克指数升高和脉压降低,40%失血组有部分恢复迹象,55%失血组代谢性酸中毒在伤后约85分钟仍持续加重。
  • 两组均见弥漫性轴索损伤(NFL/Aβ42升高)、血脑屏障破坏(免疫球蛋白G升高)和炎症(胶质纤维酸性蛋白/离子钙结合衔接分子1升高)证据。
  • 假手术组在数小时实验过程中神经和生理生物标志物也出现显著变化,最可能与长时间麻醉有关。
  • 作者认为55%失血模型可能适合需立即医疗干预/标准液体复苏的严重创伤研究,40%失血模型可能适合延长现场救治研究。

适用人群与场景

  • 22头性成熟Yucatan猪,体重30.39±2.25 kg,其中11头雌性。
  • 实验分组:假手术组n=6,创伤性脑损伤合并55%失血组n=8,创伤性脑损伤合并40%失血组n=8。

红旗征与不能漏的情况

  • 创伤性脑损伤合并55%失血组多数于伤后2小时内死于呼吸暂停。

研究设计与关键结果

  • 研究类型:大型动物(猪)实验,比较假手术、动态加速性创伤性脑损伤合并55%失血和合并40%失血。
  • 样本量:22头Yucatan猪,假手术组n=6,创伤性脑损伤合并55%失血组n=8,创伤性脑损伤合并40%失血组n=8。
  • 主要结果:创伤性脑损伤合并40%失血组存活率87.5%,显著高于合并55%失血组的12.5%,55%失血组多数于伤后2小时内死于呼吸暂停。
  • 生物标志物:两组伤后均见NFL/Aβ42升高(弥漫性轴索损伤)、免疫球蛋白G升高(血脑屏障破坏)、胶质纤维酸性蛋白/离子钙结合衔接分子1升高(炎症),均相对假手术组。
  • 血流动力学:两组休克指数升高、脉压降低,40%失血组有部分恢复迹象;55%失血组代谢性酸中毒在伤后约85分钟仍持续加重。
  • 假手术组在数小时实验过程中神经和生理生物标志物也出现显著变化,最可能与长时间麻醉有关。

证据类型、等级与局限

  • 证据类型:大型动物(猪)实验研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为创伤性脑损伤合并55%失血模型可能更适合需要立即医疗干预/标准液体复苏的严重创伤研究。
  • 作者认为创伤性脑损伤合并40%失血模型可能适合延长现场救治研究。
  • 假手术组在长时间麻醉下神经和生理生物标志物也出现显著变化,解读此类模型生物标志物时需考虑麻醉影响。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: The pathology resulting from concurrent traumatic brain injury (TBI) and hemorrhagic shock (HS; TBI+HS) are leading causes of mortality and morbidity worldwide following trauma. However, the majority of large animal models of TBI+HS have utilized focal/contusional injuries rather than incorporating the types of brain trauma (closed-head injury caused by dynamic acceleration) that typify human injury.

OBJECTIVE: To examine survival rates and effects on biomarkers from rotational TBI with two levels of HS.

METHODS: Twenty-two sexually mature Yucatan swine (30.39 ± 2.25 kg; 11 females) therefore underwent either Sham trauma procedures (n = 6) or a dynamic acceleration TBI combined with either 55% (n = 8) or 40% (n = 8) blood loss in this serial study.

RESULTS: Survival rates were significantly higher for the TBI+40% (87.5%) relative to TBI+55% (12.5%) cohort, with the majority of TBI+55% animals expiring within 2 h post-trauma from apnea. Blood-based neural biomarkers and immunohistochemistry indicated evidence of diffuse axonal injury (increased NFL/Aβ42), blood-brain barrier breach (increased immunoglobulin G) and inflammation (increased glial fibrillary acidic protein/ionized calcium-binding adaptor molecule 1) in the injured cohorts relative to Shams. Invasive hemodynamic measurements indicated increased shock index and decreased pulse pressure in both injury cohorts, with evidence of partial recovery for invasive hemodynamic measurements in the TBI+40% cohort. Similarly, although both injury groups demonstrated ionic and blood gas abnormalities immediately postinjury, metabolic acidosis continued to increase in the TBI+55% group ∼85 min postinjury. Somewhat surprisingly, both neural and physiological biomarkers showed significant changes within the Sham cohort across the multi-hour experimental procedure, most likely associated with prolonged anesthesia.

CONCLUSION: Current results suggest the TBI+55% model may be more appropriate for severe trauma requiring immediate medical attention/standard fluid resuscitation protocols whereas the TBI+40% model may be useful for studies of prolonged field care.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Mayer AR, Dodd AB, Ling JM, et al. Survival Rates and Biomarkers in a Large Animal Model of Traumatic Brain Injury Combined With Two Different Levels of Blood Loss. Shock. 2021. PMID: 32881755. doi:10.1097/SHK.0000000000001653

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。